Patents by Inventor Jeff Varelman

Jeff Varelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
    Patent number: 10596109
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: March 24, 2020
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • DIMETHYL SULFOXIDE (DMSO) OR DMSO AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT INFECTIOUS DISEASES
    Publication number: 20180214373
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: December 1, 2017
    Publication date: August 2, 2018
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
    Patent number: 9855212
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 2, 2018
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • DIMETHYL SULFOXIDE (DMSO) OR DMSO AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT INFECTIOUS DISEASES
    Publication number: 20130045941
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 21, 2013
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman